Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases

Cells Tissues Organs

Volumn 185, Issue 1-3, 2007, Pages 111-115

  Lawrence, Mitchell G ^a   Veveris Lowe, Tara L ^a   Whitbread, Astrid K ^a   Nicol, David L ^b   Clements, Judith A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

E cadherin; Epithelial mesenchymal transition; Kallikrein; Prostate; Prostate specific antigen

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE;

CANCER CELL; CANCER MORTALITY; CONFERENCE PAPER; HUMAN; MESENCHYME; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM;

ANIMALS; EPITHELIAL CELLS; EPITHELIUM; HUMANS; KALLIKREINS; MALE; MESODERM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 34250754838     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101311     Document Type: Conference Paper

References (42)

1. Amir, A.L., M. Barua, N.C. McKnight, S. Cheng, X. Yuan, S.P. Balk (2003) A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278: 30828-30834.
2. Barrack, E.R. (1997) TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31: 61-70.
3. Bhowmick, N.A., A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, H.L. Moses (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851.
4. Bonaccorsi, L., V. Carloni, M. Muratori, L. Formigli, S. Zecchi, G. Forti, E. Baldi (2004) EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR). Int J Cancer 112: 78-86.
5. Brown, K.A., M.E. Aakre, A.E. Gorska, J.O. Price, S.E. Eltom, J.A. Pietenpol, H.L. Moses (2004) Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 6: R215-R231.
6. Bryden, A.A.G., J.A. Hoyland, A.J. Freemont, N.W. Clarke, D. Schembri Wismayer, N.J.R. George (2002) E-cadherin and beta-catenin are down-regulated in prostatic bone metastases. BJU Int 89: 400-403.
7. Bussemakers, M.J., R.J. van Moorselaar, L.A. Giroldi, T. Ichikawa, J.T. Isaacs, M. Takeichi, F.M. Debruyne, J.A. Schalken (1992) Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 52: 2916-2922.
8. Chunthapong, J., E.A. Seftor, Z. Khalkhali-Ellis, R.E.B. Seftor, S. Amir, D.M. Lubaroff, P.M. Heidger, Jr., M.J.C. Hendrix (2004) Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 91: 649-661.
9. Clements, J.A., N.M. Willemsen, S.A. Myers, Y. Dong (2004) The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 41: 265-312.
10. Dallas, S.L., S. Zhao, S.D. Cramer, Z. Chen, D.M. Peehl, L.F. Bonewald (2005) Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J Cell Physiol 202: 361-370.
11. Danielpour, D. (2005) Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 41: 846-857.
12. Festuccia, C., A. Angelucci, G.L. Gravina, L. Biordi, D. Millimaggi, P. Muzi, C. Vicentini, M. Bologna (2005) Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost 93: 964-975.
13. Giles, R.H., J.H. van Es, H. Clevers (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24.
14. Gingrich, J.R., R.J. Barrios, R.A. Morton, B.F. Boyce, F.J. DeMayo, M.J. Finegold, R. Angelopoulou, J.M. Rosen, N.M. Greenberg (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56: 4096-4102.
15. Gravina, G.L., C. Festuccia, A. Angelucci, A. Poletti, D. Capuano, C. Vicentini, M. Motta, M. Bologna (2004) Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells. Int J Oncol 25: 97-104.
16. Gregory, C.W., X. Fei, L.A. Ponguta, B. He, H.M. Bill, F.S. French, E.M. Wilson (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 279: 7119-7130.
17. Hernes, E., S.D. Fossa, A. Berner, B. Otnes, J.M. Nesland (2004) Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. Br J Cancer 90: 449-454.
18. Horvath, L.G., S.M. Henshall, C.-S. Lee, J.G. Kench, D. Golovsky, P.C. Brenner, G.F. O'Neill, R. Kooner, P.D. Stricker, J.J. Grygiel, R.L. Sutherland (2005) Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. Int J Cancer 113: 415-422.
19. Jaggi, M., T. Nazemi, N.A. Abrahams, J.J. Baker, A. Galich, L.M. Smith, K.C. Balaji (2005) N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66: 193-199.
20. Jemal, A., T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, E.J. Feuer, M.J. Thun (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10-30.
21. Joesting, M.S., S. Perrin, B. Elenbaas, S.E. Fawell, J.S. Rubin, O.E. Franco, S.W. Hayward, G.R. Cunha, P.C. Marker (2005) Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res 65: 10423-10430.
22. Loric, S., V. Paradis, J.L. Gala, P. Berteau, P. Bedossa, G. Benoit, P. Eschwege (2001) Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer. Eur J Cancer 37: 1475-1481.
23. Lu, Z., S. Ghosh, Z. Wang, T. Hunter (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4 : 499-515.
24. Majumder, P.K., W.R. Sellers (2005) Akt-regulated pathways in prostate cancer. Oncogene 24: 7465-7474.
25. Mason, M.D., G. Davies, W.G. Jiang (2002) Cell adhesion molecules and adhesion abnormalities in prostate cancer. Crit Rev Oncol Hematol 41: 11-28.
26. Matsumura, M., A.S. Bhatt, D. Andress, N. Clegg, T.K. Takayama, C.S. Craik, P.S. Nelson (2005) Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate 62: 1-13.
27. Mimeault, M., S.K. Batra (2005) Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 27: 1-22.
28. Orio, F., Jr., B. Terouanne, V. Georget, S. Lumbroso, C. Avances, C. Siatka, C. Sultan (2002) Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines. Mol Cell Endocrinol 198: 105-114.
29. Park, B.J., J.I. Park, D.S. Byun, J.H. Park, S.G. Chi (2000) Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res 60: 3031-3038.
30. Parries, G., S. Cohen (1996) Proteolysis of the human epidermal growth factor precusor (proEGF) by prostate-specific antigen (abstract). American Urological Society Meeting, Orlando.
31. Radisky, D.C., D.D. Levy, L.E. Littlepage, H. Liu, C.M. Nelson, J.E. Fata, D. Leake, E.L. Godden, D.G. Albertson, M.A. Nieto, Z. Werb, M.J. Bissell (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127.
32. Rubin, M.A., N.R. Mucci, J. Figurski, A. Fecko, K.J. Pienta, M.L. Day (2001) E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 32: 690-697.
33. Sun, X., S. Donald, J. Phang (2001) Testosterone and prostate-specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis 22: 1775-1780.
34. Tarin, D. (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65: 5996-6000.
35. Thiery, J.P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
36. Thompson, E.W., D.F. Newgreen (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995.
37. Tomita, K., A. van Bokhoven, G.J.L.H. van Leenders, E.T.G. Ruijter, C.F. Jansen, M.J. Bussemakers, J.A. Schalken (2000) Cadherin switching in human prostate cancer progression. Cancer Res 60: 3650-3654.
38. Valcourt, U., M. Kowanetz, H. Niimi, C.H. Heldin, A. Moustakas (2005) TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16: 1987-2002.
39. Verras, M., Z. Sun (2005) Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 237: 22-32.
40. Veveris-Lowe, T.L., M.G. Lawrence, R.L. Collard, L. Bui, A.C. Herington, D.L. Nicol, J.A. Clements (2005) Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer 12: 631-643.
41. Yang, S., C. Zhong, B. Frenkel, A.H. Reddi, P. Roy-Burman (2005) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65: 5769-5777.
42. Zhou, B.P., M.C. Hung (2005) Wnt, hedgehog and snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis. Cell Cycle 4: 772-776.